Exact Mass: 476.153

Exact Mass Matches: 476.153

Found 31 metabolites which its exact mass value is equals to given mass value 476.153, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Erythroxyloside A

Erythroxyloside A

C20H28O13 (476.153)


   

Polygalatenoside D

Polygalatenoside D

C20H28O13 (476.153)


   

amygdalinic acid

amygdalinic acid

C20H28O13 (476.153)


   

(4-Acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranosid)|(4-acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside)|2,6-dihydroxy-4-(beta-neohesperidosyloxy)acetophenone|4beta-Neohesperidosyl-phloracetophenon|beta-Neohesperidosyl-4-phloracetophenon|Phloroacetophenone 4-O-beta-neohesperidoside|phloroacetophenone 4-neohesperidoside

(4-Acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranosid)|(4-acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside)|2,6-dihydroxy-4-(beta-neohesperidosyloxy)acetophenone|4beta-Neohesperidosyl-phloracetophenon|beta-Neohesperidosyl-4-phloracetophenon|Phloroacetophenone 4-O-beta-neohesperidoside|phloroacetophenone 4-neohesperidoside

C20H28O13 (476.153)


   

arabitol-5-O-(6-O-trans-caffeoyl)-beta-D-glucopyranoside

arabitol-5-O-(6-O-trans-caffeoyl)-beta-D-glucopyranoside

C20H28O13 (476.153)


   

5-Methoxy-2-beta-primverosyloxy-benzoesaeure-methylester|5-methoxy-2-beta-primverosyloxy-benzoic acid methyl ester

5-Methoxy-2-beta-primverosyloxy-benzoesaeure-methylester|5-methoxy-2-beta-primverosyloxy-benzoic acid methyl ester

C20H28O13 (476.153)


   

4-O-beta-D-apifuranosyl-(1->2)-beta-D-glucopyranosyl-2-hydroxy-6-methoxyacetophenone

4-O-beta-D-apifuranosyl-(1->2)-beta-D-glucopyranosyl-2-hydroxy-6-methoxyacetophenone

C20H28O13 (476.153)


   
   

(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)-phenylacetic acid|(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)phenylacetic acid|amygdalinic acid|mandelic acid beta-gentiobioside

(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)-phenylacetic acid|(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)phenylacetic acid|amygdalinic acid|mandelic acid beta-gentiobioside

C20H28O13 (476.153)


   

vanillic acid 4-O-neohesperidoside

vanillic acid 4-O-neohesperidoside

C20H28O13 (476.153)


   
   

Anti-inflammatory agent 28

Anti-inflammatory agent 28

C20H28O13 (476.153)


   

methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate

NCGC00385068-01!methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate

C20H28O13 (476.153)


   

C20H28O13_Benzoic acid, 4-methoxy-2-[(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-, methyl ester

NCGC00385068-02_C20H28O13_Benzoic acid, 4-methoxy-2-[(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-, methyl ester

C20H28O13 (476.153)


   

methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based on: CCMSLIB00000848774]

NCGC00385068-01!methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based on: CCMSLIB00000848774]

C20H28O13 (476.153)


   

methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based: Match]

NCGC00385068-01!methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based: Match]

C20H28O13 (476.153)


   
   

Primulaverin

Primulaverin

C20H28O13 (476.153)


   

Methotrexate sodium

Sodium (S)-4-carboxy-2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)butanoate

C20H21N8NaO5 (476.1533)


D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents

   

4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3-methoxybenzoic acid

4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3-methoxybenzoic acid

C20H28O13 (476.153)


   

4-hydroxy-2,5-bis(hydroxymethyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-3-yl 4-methoxybenzoate

4-hydroxy-2,5-bis(hydroxymethyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-3-yl 4-methoxybenzoate

C20H28O13 (476.153)


   

4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3-methoxybenzoic acid

4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3-methoxybenzoic acid

C20H28O13 (476.153)


   

(r)-phenyl({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy})acetic acid

(r)-phenyl({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy})acetic acid

C20H28O13 (476.153)


   

1-(4-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone

1-(4-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone

C20H28O13 (476.153)


   

(2s,3s,4r,5r)-4-hydroxy-2,5-bis(hydroxymethyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-3-yl 4-methoxybenzoate

(2s,3s,4r,5r)-4-hydroxy-2,5-bis(hydroxymethyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-3-yl 4-methoxybenzoate

C20H28O13 (476.153)


   

1-(4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,6-dihydroxyphenyl)ethanone

1-(4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,6-dihydroxyphenyl)ethanone

C20H28O13 (476.153)


   

1-(4-{[(2s,3r,4s,5r,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone

1-(4-{[(2s,3r,4s,5r,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone

C20H28O13 (476.153)


   

phenyl({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy})acetic acid

phenyl({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy})acetic acid

C20H28O13 (476.153)


   

1-(4-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone

1-(4-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone

C20H28O13 (476.153)


   

methyl 2-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}benzoate

methyl 2-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}benzoate

C20H28O13 (476.153)


   

1-(4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-2,6-dihydroxyphenyl)ethanone

1-(4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-2,6-dihydroxyphenyl)ethanone

C20H28O13 (476.153)